BeStock  
Stocks › Biotechnology › PHAR

Pharming Group PHAR

US equityMarket cap rank #3287Biotechnology
$11.54 −$0.63 (-5.18%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $11.54 0.00%
Open$11.85
Prev close$12.17
Day range$11.30 – $11.97
Volume10.5K
Market cap$816.78M
P/E (TTM)35.0
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$117.56M+20.8% YoY
Operating profit$27.59M+75.2% YoY
Net profit$22.43M+197.1% YoY
Diluted EPS$0.32+188.1% YoY
Free cash flow$32.09M+0.4% YoY
Operating cash flow$32.37M

Revenue, last 8 quarters

$92.7MDec '24$79.1MMar '25$93.2MJun '25$97.3MSep '25$106.5MDec '25$72.4MMar '26$90.2MJun '26$117.6MSep '26

Net profit, last 8 quarters

$2.9MDec '24$-14.9MMar '25$4.6MJun '25$7.5MSep '25$5.3MDec '25$-5.2MMar '26$1.6MJun '26$22.4MSep '26

Diluted EPS by quarter

0.04Dec '24-0.22Mar '250.07Jun '250.11Sep '250.07Dec '25-0.07Mar '260.02Jun '260.32Sep '26

Free cash flow by quarter

$9.2MDec '24$-56.0KMar '25$11.6MJun '25$32.0MSep '25$10.4MDec '25$1.7MMar '26$-9.7MJun '26$32.1MSep '26

Annual revenue

$212.2MFY20$198.9MFY21$205.6MFY22$245.3MFY23$297.2MFY24$376.1MFY25

Profitability & balance sheet

Gross margin85.1%
Operating margin6.7%
Net margin6.3%
Return on equity8.7%
Return on assets5.0%
Return on invested capital6.0%
Current ratio3.23
Liabilities / assets41.4%
Cash & investments$189.56M
Total debt$111.03M
Net cash (debt)$78.53M
Free cash flow / sales8.9%

Where the revenue comes from

Quarter 2026/Q1

By business line

  • RUCONEST$58.40M 80.6%
  • Joenja$14.10M 19.4%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $117.56M $90.21M $72.45M $376.13M $106.50M
Total Operating Revenue $117.56M $90.21M $72.45M $376.13M $106.50M
Cost of Revenue $15.36M $14.55M $6.64M $45.50M $21.10M
Gross Profit $102.19M $75.67M $65.80M $330.63M $85.40M
Operating Expense $74.60M $75.78M $71.09M $309.75M $83.40M
Selling and Admin Expenses $45.03M $43.52M $45.53M $117.44M $51.30M
-Selling & Marketing Expense $29.46M $28.57M $30.32M $6.66M $31.30M
-General & Admin Expense $15.57M $14.95M $15.22M $110.78M $20.00M
Research & Development $29.57M $32.26M $25.56M $100.37M $32.10M
Operating Profit $27.59M -$111,000.00 -$5.29M $20.88M $2.00M
Net Non-Operating Interest Income (Expense) $6.60M -$4.13M $542,000.00 -$8.74M -$1.40M
Total Other Finance Costs -$3.04M – – $196,000.00 –
Other Income (Expense) -$2.94M $7.28M -$8,000.00 $704,000.00 $4.20M
Earnings from Equity Interest $65,000.00 $553,000.00 -$385,000.00 $623,000.00 –
Other Non-Operating Income (Expenses) $2.30M $1.42M $377,000.00 $1.58M $4.20M
Pretax Profit $31.24M $3.04M -$4.75M $12.85M $4.80M
Tax $8.82M $1.40M $459,000.00 $10.31M -$500,000.00
Net Profit $22.43M $1.64M -$5.21M $2.54M $5.30M
Profit from Continuing Operations $22.43M $1.64M -$5.21M $2.54M $5.30M
Minority Interests $0.00 $0.00 $0.00 -$313,000.00 –
Net Income to Parent Company $22.43M $1.64M -$5.21M $2.85M $5.30M
Net Income to Common Stockholders $22.43M $1.64M -$5.21M $2.85M $5.30M
Basic EPS $0.32 $0.02 -$0.07 $0.04 $0.08
Diluted EPS $0.32 $0.02 -$0.07 $0.04 $0.07
Non-Operating Interest Income – -$1.42M $3.24M $2.18M –
Non-Operating Interest Expense – $2.68M $2.70M $10.72M $1.40M
Depreciation & Amortization & Depletion – – – $9.21M –
-Depreciation & Amortization – – – $9.21M –
Other Operating Expenses – – – $82.74M –
Gain on Sale of Security – – – -$4.88M –
Special Income (Charges) – – – $3.39M –
-Less:Impairment of Capital Assets – – – $491,000.00 –
-Less:Other Special Charges – – – -$3.88M –
-Gain on Sale of Property/Plant/Equipment – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $496.64M $467.98M $489.37M $499.96M $499.96M
Total Current Assets $322.38M $280.69M $295.51M $299.47M $299.47M
Cash and Cash Equivalents & Short-Term Investments $189.56M $158.28M $170.18M $179.10M $179.10M
-Cash and Cash Equivalents $189.56M $158.28M $52.38M $145.31M $145.31M
-Short Term Investments $0.00 $0.00 $117.80M $33.80M $33.80M
Receivables $74.83M $56.98M $60.03M $48.44M $48.44M
-Accounts Receivable $74.83M $56.98M $60.03M $41.77M $41.77M
Inventory $57.99M $65.43M $64.58M $64.90M $64.90M
Restricted Cash $0.00 $0.00 $725,000.00 $761,000.00 $761,000.00
Total Non-Current Assets $174.26M $187.30M $193.85M $200.50M $200.50M
Net PPE $19.50M $20.48M $23.10M $23.97M $23.97M
-Gross PPE $19.50M $20.48M $23.10M $60.40M $60.40M
Investments and Advances $8.59M $8.58M $8.11M $8.65M $8.65M
-Long Term Equity Investment $2.11M $2.06M $1.53M $1.94M $1.94M
Non-Current Prepaid Assets $91,000.00 $92,000.00 $93,000.00 $94,000.00 $94,000.00
Goodwill and Other Intangible Assets $125.67M $128.08M $130.99M $135.54M $135.54M
Non-Current Deferred Assets $19.05M $28.84M $30.67M $31.02M $31.02M
Other Non-Current Assets $1.36M $1.23M $894,000.00 $1.23M $1.23M
Total Liabilities $205.40M $197.49M $220.41M $222.86M $222.86M
Total Current Liabilities $99.95M $93.25M $112.35M $115.79M $115.79M
Payables $90.07M $82.32M $103.53M $14.59M $14.59M
-Accounts Payable $90.07M $82.32M $103.53M $8.55M $8.55M
Short-Term Debt and Capital Lease Obligation $9.07M $9.05M $8.15M $8.71M $8.71M
-Current Debt $5.58M $5.47M $5.38M $5.34M $5.34M
-Current Capital Lease Obligation $3.48M $3.58M $2.77M $3.37M $3.37M
Current Provisions $816,000.00 $1.88M $675,000.00 $1.19M $1.19M
Total Non-Current Liabilities $105.45M $104.25M $108.06M $107.07M $107.07M
Long Term Debt and Capital Lease Obligation $105.45M $104.25M $108.06M $107.07M $107.07M
-Long Term Debt $94.34M $92.40M $93.39M $92.72M $92.72M
-Long Term Capital Lease Obligation $11.10M $11.85M $14.67M $14.35M $14.35M
Total Equity $291.24M $270.49M $268.96M $277.10M $277.10M
Stockholders' Equity $291.24M $270.49M $268.96M $277.10M $277.10M
Capital Stock $8.09M $8.08M $8.07M $8.01M $8.01M
-Common Stock $8.09M $8.08M $8.07M $8.01M $8.01M
Additional Paid-In Capital $520.91M $520.31M $518.60M $513.26M $513.26M
Retained Earnings -$255.28M -$278.25M -$281.46M -$272.98M -$272.98M
Gains/Losses Not Affecting Retained Earnings $17.52M $20.34M $23.75M $28.82M $28.82M
Other Non-Current Liabilities – – -$1,000.00 – –
Minority Interests – – $0.00 $0.00 $0.00
-Taxes Receivable – – – $4.74M $4.74M
-Other Receivables – – – $1.93M $1.93M
Prepaid Assets – – – $6.26M $6.26M
Other Current Assets – – – $1,000.00 $1,000.00
-Accumulated Depreciation – – – -$36.43M -$36.43M
-Goodwill – – – $3.32M $3.32M
-Other Intangible Assets – – – $132.22M $132.22M
-Total Tax Payable – – – $6.04M $6.04M
Current Accrued Expenses – – – $91.31M $91.31M
Other Current Liabilities – – – -$1,000.00 -$1,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $32.37M -$9.66M $1.95M $54.71M $10.71M
Net cash flow from continuing operations $32.37M -$9.66M $1.95M $54.71M $10.71M
Net Income from Continuing Operations $31.24M $3.04M -$4.75M $12.85M $4.80M
Gain/Loss from Continuing Operations -$105,000.00 -$521,000.00 $391,000.00 -$4.36M -$4.63M
Depreciation & Depletion & Amortization $2.59M $3.04M $3.12M $11.22M $3.21M
Other Non-Cash Items -$1.32M -$1.18M -$567,000.00 $13.38M $2.29M
Change in Working Capital -$7.08M -$18.14M $445,000.00 $10.39M $1.50M
-Change in Receivables -$16.12M $5.72M -$4.40M -$3.36M -$14.81M
-Change in Inventory $1.88M -$6.99M -$264,000.00 -$1.29M $4.40M
-Change in Payables and Accrued Expense $8.36M -$18.44M $5.29M $14.13M $9.99M
-Change In Other Working Capital -$1.20M $1.58M -$181,000.00 $902,000.00 $1.92M
Net cash flow from investing -$280,000.00 -$83,000.00 -$84.76M $26.25M -$45,000.00
Net Cash Flow from Continuing Investing Activities -$280,000.00 -$83,000.00 -$84.76M $26.25M -$44,000.00
Capital Expenditure -$280,000.00 -$83,000.00 -$238,000.00 -$749,000.00 -$269,000.00
Net Intangibles Purchase and Sale $0.00 $0.00 $0.00 -$6,000.00 $0.00
Net Business Purchase and Sale $0.00 $0.00 $0.00 -$58.22M -$8,000.00
Net Investment Purchase and Sale $0.00 $0.00 -$84.52M $85.22M $233,000.00
Financing Cash Flow -$395,000.00 -$2.45M -$9.22M $1.50M $1.04M
Net Cash Flow from Continuing Financing Activities -$395,000.00 -$2.45M -$9.22M $1.50M $1.04M
Net Issuance Payments Of Debt -$909,000.00 -$919,000.00 -$12.98M -$4.25M -$1.37M
Cash Dividends Paid $0.00 $0.00 $0.00 $0.00 $0.00
Proceeds from Stock Option Exercised $605,000.00 $1.22M $3.88M $19.81M $5.25M
Ending Cash Balance $189.56M $158.28M $52.38M $145.31M $145.31M
Net Change in Cash $31.70M -$12.19M -$92.03M $82.45M $11.70M
Beginning Cash Balance $158.28M $52.38M $145.31M $54.94M $132.37M
Effect of Exchange Rate Changes -$417,000.00 $292,000.00 -$895,000.00 $7.91M $1.24M
Free Cash Flow $32.09M -$9.74M $1.71M $53.95M $10.44M
Net Other Investing Changes – – – -$1,000.00 –
Net Other Financing Charges – – – -$7.88M $0.00

Discussion

No comments yet — be the first to weigh in on PHAR.

Sign in to join the discussion.

Scroll to Top